Hydrocodone Bitartrate And Acetaminophen
Product Images NDC 67296-1574

2 FDA label images from Redpharm Drug, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrocodone Bitartrate And Acetaminophen (NDC 67296-1574). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hydroapap Label (Sdistributi18110615530 0001)

Hydroapap Label (Sdistributi18110615530 0001)
Label for Hydrocodone Bitartrate and Acetaminophen 5/325MG tablets, containing 4 tablets. The label includes the product NDC 67296-1574-0, Rx only status, lot number 41929, and expiration date 11/19. Manufactured by Tris Pharma Inc. in Monmouth Junction, NJ, and distributed by Redpharm Drug, Inc. in Eden Prairie, MN. The label also includes storage instructions and a barcode.*
FDA Label Image

Hydro/apap (Doc20180327134003 001)

Hydro/apap (Doc20180327134003 001)
Multiple pharmacy labels for Hydrocodone Bitartrate and Acetaminophen 5/325MG tablets in various tablet counts including 6, 10, 12, 15, 20, 30, 40, 50, and 60 tablets. Labels display Rx only status, lot numbers, expiration dates mostly 07/19 with one 03/20, manufacturer details as Tris Pharma Inc Monmouth Junction NJ, and distributor Redpharm Drug Eden Prairie MN. Each label includes a barcode and a 'C II' controlled substance symbol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.